Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Long-Term Debt Issuances (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Long-Term Debt Issuances came in at $147000.0 in Q1 2026, down 31.94% YoY from $216000.0 in Q1 2025, and down 88.58% on a QoQ basis from $1.3 million in Q3 2025.

Abpro Holdings (ABPO) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Long-Term Debt Issuances data on file, last reported at $147000.0 in Q1 2026.

  • Quarterly Long-Term Debt Issuances fell 31.94% year-over-year to $147000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 47.42% YoY) and the FY2025 annual result came in at $1.8 million, down 67.92% from the prior year.
  • Long-Term Debt Issuances retreated to $147000.0 in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $2.6 million in Q1 2024 to a low of -$100277.0 in Q2 2022.
  • A 5-year average of $837569.3 and a median of $858000.0 in 2024 frame the typical range for Long-Term Debt Issuances.
  • The widest YoY moves for Long-Term Debt Issuances: up 19.28% in 2025, down 91.64% in 2025.
  • Tracing ABPO's Long-Term Debt Issuances over 5 years: stood at -$100277.0 in 2022, then surged by 1538.02% to $1.4 million in 2023, then sank by 40.5% to $858000.0 in 2024, then jumped by 50.0% to $1.3 million in 2025, then plunged by 88.58% to $147000.0 in 2026.
  • The last three Long-Term Debt Issuances figures came in at $147000.0 (Q1 2026), $1.3 million (Q3 2025), and $337000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Abpro Holdings 1.14 Mn 1.14 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 147,000.00
Mar 31, 2026 147,000.00
Sep 30, 2025 1.29 Mn
Sep 30, 2025 1.29 Mn
Jun 30, 2025 337,000.00
Jun 30, 2025 337,000.00
Mar 31, 2025 216,000.00
Mar 31, 2025 216,000.00
Dec 31, 2024 858,000.00
Dec 31, 2024 858,000.00
Sep 30, 2024 1.08 Mn
Sep 30, 2024 1.08 Mn
Jun 30, 2024 1.22 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 2.58 Mn
Mar 31, 2024 2.58 Mn
Dec 31, 2023 1.44 Mn
Dec 31, 2023 1.44 Mn
Jun 30, 2022 -100,277.00
Jun 30, 2022 -100,277.00